Phase II trial of capecitabine for brain metastasis of breast cancer

Phase II trial of capecitabine for brain metastasis of breast cancer - Capecitabine-brain meta

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001530

Enrollment

Registered

2008-12-01

Start date

2007-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain metastasis of breast cancer

Interventions

Capecitabine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patient with breast cancer 2)At least one brain metastasis by RECIST 3)Prior treated patient by systemic chemotherapy

Exclusion criteria

Exclusion criteria: The patient have not indication for capecitabine therapy

Design outcomes

Primary

Measure	Time frame
Response rate	—

Countries

Japan

Contacts

Public ContactMasashi Ando

National cancer center hospital Breast and Medical Oncology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026